Works matching DE "AZACITIDINE"

Results: 987

DNA methylation patterns of Brachypodium distachyon chromosomes and their alteration by 5-azacytidine treatment.

Published in:

Chromosome Research, 2011, v. 19, n. 8, p. 955, doi. 10.1007/s10577-011-9243-2

By:

Borowska, Natalia;
Idziak, Dominika;
Hasterok, Robert

Publication type:

Article

Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01348-8

By:

Peng, Xiaohuan;
Yu, Jianing;
Tang, Futian;
Li, Yanhong;
Bai, Jun;
Li, Lijuan;
Zhang, Liansheng

Publication type:

Article

Digging deep into 'dirty' drugs - modulation of the methylation machinery.

Published in:

Drug Metabolism Reviews, 2015, v. 47, n. 2, p. 252, doi. 10.3109/03602532.2014.995379

By:

Pleyer, Lisa;
Greil, Richard

Publication type:

Article

5-AzaCytidine Promotes Somatic Embryogenesis of Taxodium Hybrid 'Zhongshanshan' by Regulating Redox Homeostasis.

Published in:

Plants (2223-7747), 2025, v. 14, n. 9, p. 1354, doi. 10.3390/plants14091354

By:

Yuan, Guoying;
Wang, Dan;
Yu, Chaoguang;
Hua, Jianfeng;
Yin, Yunlong;
Chen, Tingting

Publication type:

Article

Genome-Wide Identification of Osmanthus fragrans Histone Modification Genes and Analysis of Their Expression during the Flowering Process and under Azacytidine and Ethylene Treatments.

Published in:

Plants (2223-7747), 2024, v. 13, n. 6, p. 777, doi. 10.3390/plants13060777

By:

Xia, Hui;
Zhang, Yingting;
Chen, Xiang;
Zeng, Xiangling;
Cai, Xuan;
Li, Zeqing;
Chen, Hongguo;
Yang, Jie;
Zou, Jingjing

Publication type:

Article

An Improved Syringe Agroinfiltration Protocol to Enhance Transformation Efficiency by Combinative Use of 5-Azacytidine, Ascorbate Acid and Tween-20.

Published in:

Plants (2223-7747), 2017, v. 6, n. 1, p. 9, doi. 10.3390/plants6010009

By:

Huimin Zhao;
Zilong Tan;
Xuejing Wen;
Yucheng Wang

Publication type:

Article

Dormancy programs as emerging antimetastasis therapeutic alternatives.

Published in:

Molecular & Cellular Oncology, 2016, v. 3, n. 1, p. 1, doi. 10.1080/23723556.2015.1029062

By:

Sosa, Maria Soledad

Publication type:

Article

Toxicity and Pharmacokinetic Studies of Aerosolized Clinical Grade Azacitidine.

Published in:

2016

By:

Xuan Qiu;
Yuanxin Liang;
Sellers, Rani S.;
Perez-Soler, Roman;
Yiyu Zou;
Qiu, Xuan;
Liang, Yuanxin;
Zou, Yiyu

Publication type:

journal article

Chidamide in combination with azacitidine for an elderly patient with peripheral T cell lymphoma‑not otherwise specified: A case report.

Published in:

Oncology Letters, 2024, v. 28, n. 2, p. N.PAG, doi. 10.3892/ol.2024.14474

By:

Liu, Heng;
Xue, Feng;
Zhou, Rui;
Tian, Hongjuan;
Mao, Junfeng;
Wu, Tao

Publication type:

Article

Low‑dose venetoclax combined with azacitidine in older and frail patients with newly diagnosed acute myeloid leukaemia.

Published in:

Oncology Letters, 2024, v. 27, n. 5, p. N.PAG, doi. 10.3892/ol.2024.14362

By:

Rong, Chunmeng;
Yang, Fang;
Chen, Yalu;
Wang, Ming;
Ai, Cheng;
Luo, Yuqing;
Gao, Panpan;
Weng, Yiqin;
Huang, Xiaguang;
Gu, Meier;
Huang, Weiping;
Xia, Yongming

Publication type:

Article

Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System.

Published in:

Oncology Letters, 2024, v. 27, n. 2, p. N.PAG, doi. 10.3892/ol.2023.14193

By:

Inoue, Yu;
Okamoto, Haruya;
Miyashita, Akihiro;
Kawaji-Kanayama, Yuka;
Chinen, Shotaro;
Fujino, Takahiro;
Tsukamoto, Taku;
Shimura, Yuji;
Mizutani, Shinsuke;
Kaneko, Hiroto;
Kuwahara-Ota, Saeko;
Fuchida, Shin-Ichi;
Nishiyama, Daichi;
Hirakawa, Koichi;
Uchiyama, Hitoji;
Uoshima, Nobuhiko;
Kawata, Eri;
Kuroda, Junya

Publication type:

Article

CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia.

Published in:

Oncology Letters, 2022, v. 23, n. 2, p. N.PAG

By:

Kaito, Yuta;
Hirano, Mitsuhito;
Futami, Muneyoshi;
Nojima, Masanori;
Tamura, Hideto;
Tojo, Arinobu;
Imai, Yoichi

Publication type:

Article

Pan-RAF inhibitor LY3009120 is highly synergistic with low-dose cytarabine, but not azacitidine, in acute myeloid leukemia with RAS mutations.

Published in:

Oncology Letters, 2021, v. 22, n. 5, p. N.PAG, doi. 10.3892/ol.2021.13006

By:

Park, Jihyun;
Park, Hyejoo;
Byun, Ja Min;
Hong, Junshik;
Shin, Dong-Yeop;
Koh, Youngil;
Yoon, Sung-Soo

Publication type:

Article

Epigenetic treatment-mediated modulation of PD-L1 predicts potential therapy resistance over response markers in myeloid malignancies: A molecular mechanism involving effectors of PD-L1 reverse signaling.

Published in:

Oncology Letters, 2019, v. 17, n. 2, p. 2543

By:

Liu, Hongbin;
Hu, Yunshan;
Rimoldi, Rafael;
Von Hagt, Chloe;
Khong, Edmund W.C.;
Lee, Nora;
Flemming, Shaun;
Spencer, Andrew;
Dear, Anthony E.

Publication type:

Article

Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemia.

Published in:

Oncology Letters, 2016, v. 12, n. 4, p. 2296, doi. 10.3892/ol.2016.4970

By:

BUTRYM, ALEKSANDRA;
RYBKA, JUSTYNA;
BACZYŃSKA, DAGMARA;
PORĘBA, RAFAŁ;
MAZUR, GRZEGORZ;
KULICZKOWSKI, KAZIMIERZ

Publication type:

Article

Epigenetic regulation of miRNA-124 and multiple downstream targets is associated with treatment response in myeloid malignancies.

Published in:

Oncology Letters, 2016, v. 12, n. 3, p. 2175, doi. 10.3892/ol.2016.4912

By:

LIU, HONGBIN;
PATTIE, PHILLIP;
CHANDRASEKARA, SAHAN;
SPENCER, ANDREW;
DEAR, ANTHONY E.

Publication type:

Article

Artesunate-enhanced apoptosis of human high-risk myelodysplastic cells induced by the DNA methyltransferase inhibitor decitabine.

Published in:

Oncology Letters, 2015, v. 9, n. 6, p. 2449, doi. 10.3892/ol.2015.3121

By:

YING WANG;
FUXU WANG;
SHUPENG WEN;
YUJIE GUO;
XUAN LIU;
XUEJUN ZHANG;
LING PAN

Publication type:

Article

Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome.

Published in:

2013

By:

MELCHARDT, THOMAS;
WEISS, LUKAS;
PLEYER, LISA;
STEINKIRCHNER, SUSANNE;
AUBERGER, JUTTA;
HOPFINGER, GEORG;
GREIL, RICHARD;
EGLE, ALEXANDER

Publication type:

Case Study

Complete response to azacitidine priming and nab-paclitaxel in non-Hodgkin lymphoma resistant to biochemotherapy.

Published in:

Molecular & Clinical Oncology, 2017, v. 6, n. 1, p. 122, doi. 10.3892/mco.2016.1090

By:

BOWEN, RANDY C.;
HAHN, ANDREW W.;
BUTLER, THOMAS W.;
KHONG, HUNG T.

Publication type:

Article

Time dynamics of stress legacy in clonal transgenerational effects: A case study on Trifolium repens.

Published in:

Ecology & Evolution (20457758), 2022, v. 12, n. 5, p. 1, doi. 10.1002/ece3.8959

By:

Quan, Jiaxin;
Münzbergová, Zuzana;
Latzel, Vít

Publication type:

Article

Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2.

Published in:

Metabolites (2218-1989), 2023, v. 13, n. 4, p. 467, doi. 10.3390/metabo13040467

By:

Culp-Hill, Rachel;
Stevens, Brett M.;
Jones, Courtney L.;
Pei, Shanshan;
Dzieciatkowska, Monika;
Minhajuddin, Mohammad;
Jordan, Craig T.;
D'Alessandro, Angelo

Publication type:

Article

Invasive fungal infections in AML/ MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?

Published in:

Mycoses, 2016, v. 59, n. 8, p. 516, doi. 10.1111/myc.12500

By:

Pomares, Helena;
Arnan, Montserrat;
Sánchez‐Ortega, Isabel;
Sureda, Anna;
Duarte, Rafael F.

Publication type:

Article

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy.

Published in:

ImmunoTargets & Therapy, 2021, v. 10, p. 123, doi. 10.2147/ITT.S296161

By:

Xu, Ning;
Tse, Benjamin;
Yang, Lu;
Tang, Tiffany CY;
Haber, Michelle;
Micklethwaite, Kenneth;
Dolnikov, Alla

Publication type:

Article

Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 4, p. 567, doi. 10.1038/bmt.2013.233

By:

Tessoulin, B;
Delaunay, J;
Chevallier, P;
Loirat, M;
Ayari, S;
Peterlin, P;
Le Gouill, S;
Gastinne, T;
Moreau, P;
Mohty, M;
Guillaume, T

Publication type:

Article

Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 7, p. 994, doi. 10.1038/bmt.2012.256

By:

Antar, A;
Otrock, Z K;
Kharfan-Dabaja, M;
Salem, Z;
Aractingi, S;
Mohty, M;
Bazarbachi, A

Publication type:

Article

Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 5, p. 678, doi. 10.1038/bmt.2012.214

By:

Shin, S-H;
Yahng, S-A;
Yoon, J-H;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Lee, S;
Min, C-K;
Kim, H-J;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Min, W-S;
Park, C-W;
Kim, Y-J

Publication type:

Article

Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 3, p. 374, doi. 10.1038/bmt.2011.86

By:

Kim, D-Y;
Lee, J-H;
Park, Y-H;
Kim, S-D;
Choi, Y;
Lee, S-B;
Lee, K-H;
Ahn, S Y;
Lee, Y-S;
Seol, M;
Kang, Y-A;
Jeon, M;
Jung, A R;
Lee, Y-J

Publication type:

Article

Transcriptomic Profiles of MV4-11 and Kasumi 1 Acute Myeloid Leukemia Cell Lines Modulated by Epigenetic Modifiers Trichostatin A and 5-Azacytidine.

Published in:

International Journal of Hematology-Oncology & Stem Cell Research, 2020, v. 14, n. 1, p. 72

By:

Asmaa, Mat Jusoh Siti;
Al-Jama, Hamid Ali;
Hussein, Abdul Rahim;
Yahaya, Badrul Hisham;
Husin, Azlan;
Hassan, Roslin;
Hussain, Faezahtul Arbaeyah;
Shamsuddin, Shaharum;
Johan, Muhammad Farid

Publication type:

Article

Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia.

Published in:

Drugs, 2016, v. 76, n. 8, p. 889, doi. 10.1007/s40265-016-0585-0

By:

Scott, Lesley

Publication type:

Article

Erratum.

Published in:: 2012
Publication type:: Correction Notice

Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia.

Published in:

2021

By:

Huschart, Emily;
Miller, Holly;
Salzberg, Dana;
Campbell, Courtney;
Beebe, Kristen;
Schwalbach, Charlotte;
Magee, Kyrie;
Adams, Roberta H.;
Ngwube, Alexander

Publication type:

Report

AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances.

Published in:

Genes, 2020, v. 11, n. 8, p. 845, doi. 10.3390/genes11080845

By:

Koenig, Kristin L.;
Sahasrabudhe, Kieran D.;
Sigmund, Audrey M.;
Bhatnagar, Bhavana

Publication type:

Article

Epigenetic Modulation with 5-Aza-CdR Prevents Metabolic-Associated Fatty Liver Disease Promoted by Maternal Overnutrition.

Published in:

Nutrients, 2025, v. 17, n. 1, p. 106, doi. 10.3390/nu17010106

By:

Cheng, Henghui;
Wu, Jie;
Peng, Hui;
Li, Jiangyuan;
Liu, Zhimin;
Wang, Xian;
Zhang, Ke;
Xie, Linglin

Publication type:

Article

FMS-Like Tyrosine Kinase 3 Inhibitors in the Treatment of Acute Myeloid Leukemia: An Update on the Emerging Evidence and Safety Profile.

Published in:

OncoTargets & Therapy, 2023, v. 16, p. 31, doi. 10.2147/OTT.S236740

By:

Garciaz, Sylvain;
Hospital, Marie-Anne

Publication type:

Article

Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine.

Published in:

OncoTargets & Therapy, 2022, v. 15, p. 159, doi. 10.2147/OTT.S336715

By:

Zhang, Lei-Si;
Wang, Jun;
Xu, Ming-Zhu;
Wu, Tian-Mei;
Huang, Si-Man;
Cao, Han-Yu;
Sun, Ai-Ning;
Liu, Song-Bai;
Xue, Sheng-Li

Publication type:

Article

5-Azacytidine treatment induces demethylation of DAPK1 and MGMT genes and inhibits growth in canine mammary gland tumor cells.

Published in:

OncoTargets & Therapy, 2018, v. 11, p. 2805, doi. 10.2147/OTT.S162381

By:

Ren, Xiaoli;
Li, Huatao;
Song, Xianyi;
Wu, Yuhong;
Liu, Yun

Publication type:

Article

Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells.

Published in:

OncoTargets & Therapy, 2017, v. 10, p. 2993, doi. 10.2147/OTT.S136218

By:

Yang Yang;
Jiang Fan;
Wei Yin;
Fengying Wu

Publication type:

Article

Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report.

Published in:

2016

By:

Garcia-Recio, Marta;
Martinez-Serra, Jordi;
Bento, Leyre;
Ramos, Rafael;
Gines, Jordi;
Daumal, Jaime;
Sampol, Antonia;
Gutierrez, Antonio

Publication type:

Case Study

Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML.

Published in:

Clinical Epigenetics, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13148-024-01687-x

By:

Chatzilygeroudi, Theodora;
Chondrou, Vasiliki;
Boers, Ruben;
Siamoglou, Stavroula;
Athanasopoulou, Katerina;
Verigou, Evgenia;
Gribnau, Joost;
Alexis, Spyridon;
Labropoulou, Vassiliki;
Kourakli, Alexandra;
Patrinos, George P.;
Sgourou, Argyro;
Symeonidis, Argiris

Publication type:

Article

Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen.

Published in:

Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01580-z

By:

Schmutz, Maximilian;
Zucknick, Manuela;
Schlenk, Richard F.;
Mertens, Daniel;
Benner, Axel;
Weichenhan, Dieter;
Mücke, Oliver;
Döhner, Konstanze;
Plass, Christoph;
Bullinger, Lars;
Claus, Rainer

Publication type:

Article

A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes.

Published in:

Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01441-9

By:

Mongiorgi, Sara;
De Stefano, Alessia;
Ratti, Stefano;
Indio, Valentina;
Astolfi, Annalisa;
Casalin, Irene;
Pellagatti, Andrea;
Paolini, Stefania;
Parisi, Sarah;
Cavo, Michele;
Pession, Andrea;
McCubrey, James A.;
Suh, Pann-Ghill;
Manzoli, Lucia;
Boultwood, Jacqueline;
Finelli, Carlo;
Cocco, Lucio;
Follo, Matilde Y.

Publication type:

Article

The possibility of early diagnosis of colorectal cancer through expression of Lncrna UCA1, Lncrna LINC00970, and Wnt genes; an in-vitro study.

Published in:

Acta Scientiarum: Health Sciences, 2022, v. 44, n. 1, p. 1, doi. 10.4025/actascihealthsci.v44i1.56960

By:

Razavi, Seyedeh Medisa Sadat;
Maleki, Narges;
Jamshidian, Faranak

Publication type:

Article

Azacitidine Combined with Cytarabine in Older Patients with Newly Diagnosed AML.

Published in:

International Journal of Gerontology, 2022, v. 16, n. 1, p. 57, doi. 10.6890/IJGE.202201_16(1).0011

By:

Shijun Li;
Junyuan Qi;
Bo Jiang

Publication type:

Article

5-Azacytidine treatment and <italic>TaPBF</italic>-<italic>D</italic> over-expression increases glutenin accumulation within the wheat grain by hypomethylating the <italic>Glu</italic>-<italic>1</italic> promoters.

Published in:

Theoretical & Applied Genetics, 2018, v. 131, n. 3, p. 735, doi. 10.1007/s00122-017-3032-z

By:

Zhu, Jiantang;
Fang, Linlin;
Yu, Jiaqi;
Zhao, Ying;
Chen, Fanguo;
Xia, Guangmin

Publication type:

Article

Azacitidine-induced myopericarditis in acute myeloid leukemia.

Published in:

Baylor University Medical Center Proceedings, 2022, v. 35, n. 6, p. 849, doi. 10.1080/08998280.2022.2111642

By:

Ismayl, Mahmoud;
KC, Asmini;
Thandra, Abhishek;
Sricharoen, Nattapong;
Arouni, Amy

Publication type:

Article

Cost-effectiveness analysis for midostaurin versus standard of care in acute myeloid leukemia in the United Kingdom.

Published in:

Cost Effectiveness & Resource Allocation, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12962-018-0153-4

By:

Tremblay, Gabriel;
Dolph, Mike;
Patel, Sachin;
Brandt, Patricia;
Forsythe, Anna

Publication type:

Article

Azacitidine in outpatient treatment - single center experience.

Published in:

Contemporary Oncology / Współczesna Onkologia, 2015, v. 19, n. 6, p. 467, doi. 10.5114/wo.2015.56653

By:

Rybka, Justyna;
Stefanko, Ewa;
Bogucka-Fedorczuk, Aleksandra;
Butrym, Aleksandra;
Poręba, Rafał;
Kuliczkowski, Kazimierz;
Wróbel, Tomasz

Publication type:

Article

Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1460-1

By:

Adomako, Alfred;
Calvo, Veronica;
Biran, Noa;
Osman, Keren;
Chari, Ajai;
Paton, James C.;
Paton, Adrienne W.;
Moore, Kateri;
Schewe, Denis M.;
Aguirre-Ghiso, Julio A.

Publication type:

Article

Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis.

Published in:

2014

By:

Jin, Zhe;
Wang, Liang;
Cao, Ziyi;
Cheng, Yulan;
Gao, Yan;
Feng, Xianling;
Chen, Si;
Yu, Huimin;
Wu, Wenjing;
Zhao, Zhenfu;
Dong, Ming;
Zhang, Xiaojing;
Liu, Jie;
Fan, Xinmin;
Mori, Yuriko;
Meltzer, Stephen J

Publication type:

journal article

LEUKEMIA.

Published in:: Oncology (08909091), 2022, v. 36, n. 2, p. 130
Publication type:: Article